JAMP NITROFURANTOIN DIN 02495511
Health Canada record
| Active ingredient(s) | NITROFURANTOIN 100 MG |
|---|---|
| Dosage form | Capsule |
| Route | Oral |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | J01XE01 NITROFURANTOIN |
| Original market date | 02-Apr-2025 |
| Current status date | 02-Apr-2025 |
| Source | Health Canada DPD |
Establishment licence of the holder
Jamp Pharma Corporation — licence 100590, currently licensed, last inspection rating C (2025-01-13).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing NITROFURANTOIN
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02466392 | AURO-NITROFURANTOIN BID | AURO PHARMA INC | Capsule | NITROFURANTOIN 100 MG | Marketed |
| 02495503 | JAMP NITROFURANTOIN | JAMP PHARMA CORPORATION | Capsule | NITROFURANTOIN 50 MG | Marketed |
| 02544954 | JAMP NITROFURANTOIN BID | JAMP PHARMA CORPORATION | Capsule | NITROFURANTOIN 100 MG | Marketed |
| 00312738 | NITROFURANTOIN | AA PHARMA INC | Tablet | NITROFURANTOIN 100 MG | Marketed |
| 00319511 | NITROFURANTOIN | AA PHARMA INC | Tablet | NITROFURANTOIN 50 MG | Marketed |
| 02455676 | PMS-NITROFURANTOIN BID | PHARMASCIENCE INC | Capsule | NITROFURANTOIN 100 MG | Marketed |
| 02231015 | TEVA-NITROFURANTOIN | TEVA CANADA LIMITED | Capsule | NITROFURANTOIN 50 MG | Marketed |
| 02231016 | TEVA-NITROFURANTOIN | TEVA CANADA LIMITED | Capsule | NITROFURANTOIN 100 MG | Marketed |
| 02016842 | EQUIFUR NITROFURANTOIN SUSPENSION | VETOQUINOL N A INC | Suspension | NITROFURANTOIN 15 MG | Cancelled Post Market |
| 00712760 | FURAFLU SUS 15MG/ML | LANGFORD | Suspension | NITROFURANTOIN 15 MG | Cancelled Post Market |
| 02386542 | FURANTOIN SUSPENSION | WECAN SALES LTD | Suspension | NITROFURANTOIN 15 MG | Dormant |
| 02063662 | MACROBID | ALLERGAN INC | Capsule | NITROFURANTOIN 100 MG | Cancelled Post Market |
| 01997599 | MACRODANTIN | ALZA CORPORATION | Capsule | NITROFURANTOIN 25 MG | Cancelled Post Market |
| 01997645 | MACRODANTIN (100 MG) | PROCTER & GAMBLE PHARMACEUTICALS CANADA INC | Capsule | NITROFURANTOIN 100 MG | Cancelled Post Market |
| 01997637 | MACRODANTIN (50 MG) | PROCTER & GAMBLE PHARMACEUTICALS CANADA INC | Capsule | NITROFURANTOIN 50 MG | Cancelled Post Market |
| 00452483 | MACRODANTIN CAP 100MG | NORWICH EATON CANADA INC. | Capsule | NITROFURANTOIN 100 MG | Cancelled Post Market |
| 00452491 | MACRODANTIN CAP 25MG | NORWICH EATON CANADA INC. | Capsule | NITROFURANTOIN 25 MG | Cancelled Post Market |
| 00452505 | MACRODANTIN CAP 50MG | NORWICH EATON CANADA INC. | Capsule | NITROFURANTOIN 50 MG | Cancelled Post Market |
| 00082783 | NEPHRONEX TAB 50MG | LABORATOIRES CORTUNON INC. | Tablet | NITROFURANTOIN 50 MG | Cancelled Post Market |
| 00563773 | NITROFURANTOIN 50 TAB 50MG | PRO DOC LIMITEE | Tablet | NITROFURANTOIN 50 MG | Cancelled Post Market |
| 00563765 | NITROFURANTOINE 100 TAB 100MG | PRO DOC LIMITEE | Tablet | NITROFURANTOIN 100 MG | Cancelled Post Market |
| 00021571 | NOVO-FURAN 100MG | NOVOPHARM LIMITED | Tablet | NITROFURANTOIN 100 MG | Cancelled Post Market |
| 00232971 | NOVO-FURAN SUS 25MG/5ML | NOVOPHARM LIMITED | Suspension | NITROFURANTOIN 5 MG | Cancelled Post Market |
| 00021563 | NOVO-FURAN TAB 50MG | NOVOPHARM LIMITED | Tablet | NITROFURANTOIN 50 MG | Cancelled Post Market |
| 02239232 | NU-NITROFURANTOIN TABLETS | NU-PHARM INC | Tablet | NITROFURANTOIN 100 MG | Cancelled (Unreturned Annual) |
| 02239231 | NU-NITROFURANTOIN TABLETS | NU-PHARM INC | Tablet | NITROFURANTOIN 50 MG | Cancelled (Unreturned Annual) |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 23097 | 2020-01-10 | Abbreviated New Drug Submission (ANDS) |
International API supply for NITROFURANTOIN
3 valid EDQM Certificates of Suitability from 3 holders. 26 active FDA Drug Master Files.
Request a quote for JAMP NITROFURANTOIN